Business Wire

DEEP-DIVE-GLOBAL-CANAL

24.11.2022 12:23:38 CET | Business Wire | Press release

Share
Deep Dive Global Canal Rowing Action Concludes World Tour With Fruitful Achievements

Covering more than 100 cities in five continents in more than one year, the Deep Dive Global Canal Rowing Action concluded its last leg of the world tour with a global rowing relay in around 20 cities worldwide recently, highlighted the action with fruitful achievements.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221124005072/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Jean-Christophe Rolland, World Rowing Federation president (L3) delivers special honor certificate to Wang Shi (R3), honorary president of Asian Rowing Federation and the action’s team leader in Sharm El-Sheikh during the 2022 United Nations Climate Change Conference (COP27) on 14 Nov. 2022. (Photo: Business Wire)

“On the same day, we held great celebrations both in Yangzhou, a major city along the ancient China’s Grand Canal, and in Cairo, one of the most famous cities along the Nile, the longest river worldwide,” said Feng Nan, president of Deep Dive Sports and Health of China and the organizer of the action. “The two cities thousands of kilometers apart, together with other cities participated and witnessed the successful action, making a clear sign that action has won wide endorsement."

The Deep Dive Action, initially co-organized by the World Historic and Cultural Canal Cities Cooperation Organization (WCCO), an international organization headquartered in Yangzhou, and the Shenzhen Foundation for International Exchange and Cooperation (SFIEC) of China, is aiming to promote the idea of sports, health and environmental protection by holding rowing events in canal cities around the world.

“It’s a milestone in the history of rowing. It’s also a great worldwide environmental awareness campaign,” Feng stressed.

Starting from China’s Grand Canal in September 2021, the campaign has been held successfully on the Potomac River in Washington, the Thames in London, the Seine in Paris, the Donau in Vienna, etc., attracting more than 2,000 international paddlers.

Jean-Christophe Rolland, World Rowing Federation president, highly praised the event. “More important was the powerful message carried out by this mission, which connected and inspired the rowing family to make a difference in this regard,” he stated in a signed letter.

At a side event held in Sharm El-Sheikh during the 2022 United Nations Climate Change Conference (COP27), Rolland also delivered his appreciation especially to Wang Shi, honorary president of Asian Rowing Federation and the action’s team leader, “It is great to see your incredible environmental advocacy, initiated during your presidency at the Asian Rowing Federation, and continuing since.”

“The action connected different cities and different cultures, and raised environmental awareness of many people under the slogan of ‘zero carbon, zero waste and clean water’,” Feng added, “A new plan of the campaign for the next year is in the pipeline.”

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221124005072/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release

As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release

Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release

Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 15:00:00 CEST | Press release

Appointment Reflects Firm's Vision for the Future of Legal Practice Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye